Archives

Archive for February, 2014

fundamental priorities…

Last night when I was looking for what I’d read previously about the Zohydro™ER issue, I couldn’t find what I was looking for. Here are a few of the articles I couldn’t find: Emails point to ‘troubling’ relationship between drug firms, regulators. Milwaukee Journal Sentinal, October 6, 2013 Pharmaceutical firms paid to attend meetings of […]

a very big rat…

If you work in the medical field, you know that prescription narcotics have become a major drug of abuse in the US. When I started working in a charity clinic in Appalachia, I was stunned by the number of people on Narcotics and how many times I was asked for a refill. When I renewed […]

a surprising finding…

Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants Psychiatry Research by John Read, Claire Cartwright, and Kerry Gibson 3 February 2014 Background: In the context of rapidly increasing antidepressant use internationally, and recent reviews raising concerns about efficacy and adverse effects, this study aimed to survey the largest sample of […]

foot-in-mouth disease…

Boehringer Kept Pradaxa Analysis From FDA, Records Show Bloomberg By Jef Feeley and Michelle Fay Cortez Feb 25, 2014 Boehringer Ingelheim GmbH didn’t disclose a data analysis to U.S. regulators that indicated the blood-thinner Pradaxa may have caused more fatal bleeding after it was cleared for sale than the drug did in a study used […]

parsing sin…

According to Roman Catholicism, a venial sin [meaning "forgivable" sin] is a lesser sin that does not result in a complete separation from God and eternal damnation in Hell. A venial sin involves a "partial loss of grace" from God. They do not break one’s friendship with God, but injure it. Wikipedia GlaxoChinaGate contd. – […]

how many examples?…

This post has nothing to do with psychiatry, but everything to do with the pharmaceutical world. It’s about the so-called blood thinners, anticoagulants taken to decrease clotting in conditions like atrial fibrillation, a heart rhythm abnormality associated with clot formation that can lead to stroke. The standard drug, Warfarin, has been in use since the […]

or maybe never…

I love the Olympics. It’s always the same. It starts with great conflict in the air – the Ukraine, Terrorists, discrimination, not-ready hotel rooms, who was that lady sitting with Putin?, etc. And then things settle down and you worry about the US atheletes for a while, crestfallen when the heros lose. And by the […]

coming back!

Ever since the abrupt disappearance of Pharmalot [January 1, 2014 gulp…], I’ve missed it every morning. I knew it was important, but I had no idea how important until it wasn’t there. Other blogs report the pharma stories [like Jack Friday at Pharmagossip], and I’m amazed that they’re so good at finding them. But nobody […]

on time…

I was pretty impressed with Dr. Cara L. Alfaro’s FDA Medical Review of Lurisadone and questioned the FDA Director’s doing another review that lead to approval, The other time where that happened was with Zoloft®, a drug that, in my opinion, also shouldn’t have been approved [zoloft: the approval I…, zoloft: the approval II…, zoloft: […]

perhaps bigger…

Ever since Richard Noll, a psychologist scholar at DeSales University, wrote an article called When Psychiatry Battled the Devil [online full text on Gary Greenberg’s site] for the Psychiatric Times about the epidemic of interest in fictive reports of ritualized abuse by satanic cults in the late 1980s, the story continues to get as bizarre […]